{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:10:54Z","timestamp":1789506654123,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018806","name":"Department of Science and Technology of Hubei Province","doi-asserted-by":"publisher","award":["2023BCB028"],"award-info":[{"award-number":["2023BCB028"]}],"id":[{"id":"10.13039\/501100018806","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vaccine.2026.128957","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:10:24Z","timestamp":1784949024000},"page":"128957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["In-depth monitoring of host cell proteins in influenza vaccines throughout multi-step purification processes"],"prefix":"10.1016","volume":"88","author":[{"given":"Bo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengliang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quangang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiejing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhegang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengli","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longjiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2026.128957_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10111873","article-title":"The epidemiology of influenza and the associated vaccines development in China: a review","volume":"10","author":"Zhang","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.128957_bb0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1743-422X-10-141","article-title":"Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches","volume":"10","author":"Thompson","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2026.128957_bb0015","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.virusres.2009.04.005","article-title":"Influenza vaccines based onvirus-like particles","volume":"143","author":"Kang","year":"2009","journal-title":"Virus Res"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128957_bb0020","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1016\/S1473-3099(18)30490-0","article-title":"The efficacy, effectiveness, and immunogenicity of influenza vaccines in Africa: a systematic review","volume":"19","author":"Lindsey","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128957_bb0025","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/irv.12694","article-title":"Comparison of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for selective isolation of influenza viruses to be used as vaccine seeds","volume":"14","author":"Harada","year":"2020","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2026.128957_bb0030","article-title":"Enhanced downstream processing for a cell-based avian influenza (H5N1) vaccine","volume":"12","author":"Li","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.128957_bb0035","article-title":"Preclinical immunogenicity assessment of a cell \u2013based inactivated whole-virion H5N1 influenza vaccine","volume":"17","author":"Zhang","year":"2022","journal-title":"Open Life Sci"},{"key":"10.1016\/j.vaccine.2026.128957_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.974381","article-title":"Annexin A2 and kidney diseases","volume":"10","author":"Lin","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.vaccine.2026.128957_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113558","article-title":"A quantitative model for virus uncoating predicts influenza A infectivity","volume":"42","author":"Artcibasova","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2026.128957_bb0050","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1016\/j.vaccine.2019.04.077","article-title":"Purification of yellow fever virus produced in Vero cells for inactivated vaccine manufacture","volume":"37","author":"Pato","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128957_bb0055","article-title":"Improved clearance of host cell protein impurities at the polishing purification step using multimodal chromatography","volume":"1732","author":"Hutchinson","year":"2023","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.vaccine.2026.128957_bb0060","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-023-00852-z","article-title":"Immunoinformatic risk assessment of host cell proteins during process development for biologic therapeutics","volume":"25","author":"Haltaufderhyde","year":"2023","journal-title":"AAPS J"},{"key":"10.1016\/j.vaccine.2026.128957_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2005.05.022","article-title":"Downstream processing of MDCK cell-derived equine influenza virus","volume":"823","author":"Nayak","year":"2005","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.vaccine.2026.128957_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/bit.21139","article-title":"Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines","volume":"97","author":"Kalbfuss","year":"2007","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2026.128957_bb0075","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/hum.1993.4.5-609","article-title":"Increased viral titer through concentration of viral harvests from retroviral packaging lines","volume":"4","author":"Paul","year":"1993","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2026.128957_bb0080","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.1016\/j.vaccine.2019.05.066","article-title":"Purification of flavivirus VLPs by a two-step chomatographic process","volume":"37","author":"T\u00falio","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128957_bb0085","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.16077","article-title":"Metabolomics profiling reveals differences in proliferation between tumorigenic and non-tumorigenic Madin-Darby canine kidney (MDCK) cells","volume":"11","author":"Sun","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/j.vaccine.2026.128957_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.biologicals.2023.101697","article-title":"CDC20 is a potential target gene to inhibit the tumorigenesis of MDCK cells","volume":"83","author":"Liu","year":"2023","journal-title":"Biologicals"},{"issue":"462","key":"10.1016\/j.vaccine.2026.128957_bb0095","first-page":"314","article-title":"Protein adsorption on core-shell particles: comparison of Capto Core 400 and 700 resins","volume":"1651","author":"Mi","year":"2021","journal-title":"J Chromatogr A"},{"issue":"31","key":"10.1016\/j.vaccine.2026.128957_bb0100","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.1016\/j.chroma.2011.06.043","article-title":"Downstream processing of Vero cell-derived human influenza a virus (H1N1) grown in serum-free medium","volume":"1218","author":"He","year":"2011","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.vaccine.2026.128957_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/bit.21109","article-title":"Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatography","volume":"96","author":"Kalbfuss","year":"2007","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2026.128957_bb0110","article-title":"Broadly neutralizing antibodies to combat influenza virus infection","volume":"221","author":"Sun","year":"2023","journal-title":"Antivir Res"},{"key":"10.1016\/j.vaccine.2026.128957_bb0115","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1039\/c3an00086a","article-title":"Subtyping of influenza neuraminidase using mass spectrometry","volume":"138","author":"Nguyen","year":"2013","journal-title":"Analyst"},{"key":"10.1016\/j.vaccine.2026.128957_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2020.113577","article-title":"Development and fit-for-purpose verification of an LC-MS method for quantitation of hemagglutinin and neuraminidase proteins in influenza virus \u2013like particle vaccine candidates","volume":"592","author":"Guo","year":"2020","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2026.128957_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2012.05.036","article-title":"Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC-MSE","volume":"30","author":"Creskey","year":"2012","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.vaccine.2026.128957_bb0130","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1016\/j.vaccine.2005.04.042","article-title":"Estimation of the neuraminidase content of influenza viruses and split-product vaccines by immunochromatography","volume":"23","author":"Tanimoto","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128957_bb0135","article-title":"Versatile LC-MS-based workflow with robust 0.1 ppm sensitivity for identifying residual HCPs in biotherapeutic products","volume":"94","author":"Yang","year":"2022","journal-title":"Anal Chem"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128957_bb0140","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1128\/JCM.02315-13","article-title":"Incorporation of a proteotyping approach using mass spectrometry for surveillance of influenza virus in cell-cultured strains","volume":"52","author":"Fernandes","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2026.128957_bb0145","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jviromet.2014.11.014","article-title":"Rapid and generic identification of influenza a and other respiratory viruses with mass spectrometry","volume":"213","author":"Majchrzykiewicz-Koehorst","year":"2015","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2026.128957_bb0150","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jviromet.2010.01.015","article-title":"Typing of human and animal strains of influenza virus with conserved signature peptides of matrix M1 protein by high resolution mass spectrometry","volume":"165","author":"Schwahn","year":"2010","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2026.128957_bb0155","first-page":"266","article-title":"FluTyper \u2013 an algorithm for automated typing and subtyping of the influenza virus from high resolution mass spectral data","volume":"26","author":"Wong","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2026.128957_bb0160","doi-asserted-by":"crossref","DOI":"10.1111\/irv.12001","article-title":"Label-free mass spectrometry-based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines","volume":"7","author":"Getie-Kebtie","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2026.128957_bb0165","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1016\/j.vaccine.2017.07.049","article-title":"Immunocapture isotope dilution mass spectrometry in response to a pandemic in-fluenza threat","volume":"35","author":"Pierce","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128957_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105639","article-title":"Development of MDCK-based quadrivalent split seasonal influenza virus vaccine with high safety and immunoprotection: a preclinical study","volume":"216","author":"Zhang","year":"2023","journal-title":"Antivir Res"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128957_bb0175","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M500230-MCP200","article-title":"Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition","volume":"5","author":"Silva","year":"2006","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.vaccine.2026.128957_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105591","article-title":"Identification of broad-spectrum neutralizing antibodies against influenza A virus and evaluation of their prophylactic efficacy in mice","volume":"213","author":"Son","year":"2023","journal-title":"Antivir Res"},{"key":"10.1016\/j.vaccine.2026.128957_bb0185","article-title":"Beyond viability: advancing CHO cell culture process strategies to modulate host cell protein levels","volume":"84","author":"Sahoo","year":"2023","journal-title":"New Biotechnol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128957_bb0190","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2213365","article-title":"Technical advancement and practical considerations of LC-MS\/MS-based methods for host cell protein identification and quantitation to support process development","volume":"15","author":"Guo","year":"2023","journal-title":"mAbs"},{"key":"10.1016\/j.vaccine.2026.128957_bb0195","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1016\/j.vaccine.2014.04.033","article-title":"Efficient chromatographic reduction of ovalbumin for egg-based influenza virus purification","volume":"32","author":"Blom","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128957_bb0200","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/bit.28678","article-title":"Host cell protein networks as a novel co-elution mechanism during protein a chromatography","volume":"121","author":"Panikulam","year":"2024","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2026.128957_bb0205","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-41442-z","article-title":"Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets","volume":"14","author":"Haas","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.128957_bb0210","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2023.2237222","article-title":"Annexin A2: the missing piece in the puzzle of pathogen-induced damage","volume":"14","author":"Li","year":"2023","journal-title":"Virulence"},{"key":"10.1016\/j.vaccine.2026.128957_bb0215","article-title":"AP3B1 facilitates PDIA3\/ERP57 function to regulate rabies virus glycoprotein selective degradation and viral entry","volume":"20","author":"Zhang","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.vaccine.2026.128957_bb0220","article-title":"Chemical hypoxic preconditioning improves survival and proliferation of mesenchymal stem cells","volume":"196","author":"Haneef","year":"2023","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1016\/j.vaccine.2026.128957_bb0225","article-title":"A unified purification method for actin \u2013binding proteins using a TEV-cleavable His-Strep-tag","volume":"13","author":"Nakajima","year":"2023","journal-title":"MethodsX"},{"key":"10.1016\/j.vaccine.2026.128957_bb0230","article-title":"Proteomic analysis of host cell protein fouling during bioreactor harvesting","volume":"40","author":"Zhang","year":"2023","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.vaccine.2026.128957_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/bit.28325","article-title":"Characterization and implications of host \u2013cell protein aggregates in biopharmaceutical processing","volume":"120","author":"Oh","year":"2023","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2026.128957_bb0240","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00786-22","article-title":"PSMD12-mediated M1 ubiquitination of influenza A virus at K102 regulates viral replication","volume":"96","author":"Hui","year":"2022","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128957_bb0245","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13036-026-00685-2","article-title":"Host cell protein impurities in therapeutic proteins: overview of advances in detection, nonconventional removal technologies and immunogenicity assessment","volume":"20","author":"Alhuthali","year":"2026","journal-title":"J Biol Eng"},{"key":"10.1016\/j.vaccine.2026.128957_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2025.108575","article-title":"Host cell protein-mediated adjuvanticity and immunogenicity risks of biotherapeutics","volume":"81","author":"Panikulam","year":"2025","journal-title":"Biotechnol Adv"},{"issue":"13","key":"10.1016\/j.vaccine.2026.128957_bb0255","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1002\/jssc.200800076","article-title":"Tailoring orthogonal proteomic routines to understand protein separation during ion exchange chromatography","volume":"31","author":"Cabrera","year":"2008","journal-title":"J Sep Sci"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2026.128957_bb0260","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.chroma.2007.02.036","article-title":"Global screening of protein chromatographic behavior on ion exchangers from a complex cell proteome","volume":"1161","author":"Cabrera","year":"2007","journal-title":"J Chromatogr A"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128957_bb0265","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.cjche.2020.01.006","article-title":"Protein retention in dextran-grafted cation exchange chromatography: the influence of pHs, counterions and polymer structure","volume":"28","author":"Liu","year":"2020","journal-title":"Chin J Chem Eng"},{"issue":"16","key":"10.1016\/j.vaccine.2026.128957_bb0270","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.3390\/molecules30163389","article-title":"Protein adsorption on a multimodal cation exchanger: effect of pH, salt type and concentration, and elution conditions","volume":"30","author":"Kr\u00e1zel Adam\u00edkov\u00e1","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.vaccine.2026.128957_bb0275","article-title":"Rapid nuclease-assisted selection of high-affinity small-molecule aptamers","volume":"146","author":"Wang","year":"2023","journal-title":"J Am Chem Soc"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:35:03Z","timestamp":1789504503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26007668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":55,"alternative-id":["S0264410X26007668"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128957","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-depth monitoring of host cell proteins in influenza vaccines throughout multi-step purification processes","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128957"}}